The official blog of the Lung Institute.

What is My Why? Melissa Rubio

31 Jan 2018
| Under Featured | Posted by | 0 Comments
What Is My Why_Melissa

A featured series where Lung Institute employees tell their stories #WhatIsMyWhy

I am the Nurse Practitioner at the Lung Health Institute in Dallas, Texas, and have been with the company since 2015.  I have earned a Ph.D. in Nursing and focus on the collection of research data and patient outcomes.

I was drawn to the Lung Health Institute for various reasons. First, lung health is extremely important to me and second, I am able to see the difference our treatment can make for those with chronic lung disease.

Devoted to the Profession

My previous medical positions involved internal medicine and primary care where I treated chronic lung disease patients with inhalers, steroids and sometimes antibiotics. I witnessed having to tell a patient that there was nothing more we could do to help them. I referred patients for lung-transplant workup and often they were denied because of advanced age, other medical problems or that they were too sick for surgery. Even though I was prescribing treatment, I was witnessing many patients caught in the cycle of exacerbations and hospitalizations.

Family History Motivated Me

While I was growing up, most of the people in my family smoked.  I hated it. Both my grandmother and mother passed away from lung cancer very young and I experienced first-hand the consequences of their smoking.

My doctoral research program has been focused on addiction, including smoking and nicotine addiction. For obvious reasons, lung health is very dear to my heart not only in my personal life but my professional life. The ability to help guide patients through lung wellness using such an innovative and promising treatment as cell therapy is very important to me.

Each and every day I am motivated by the thought that we can offer something that may help people who have not been able to hear hopeful words in a long time.  Finally, there is an alternative to traditional medical treatment of chronic lung disease.

We are the Future of Medicine

I am thrilled to be part of the future of medicine and harnessing the remarkable power of our own cells. I am excited about what we do. For me this is not a job, but a calling.


* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. The Lung Institute is firmly in accordance with the conditions set by the FDA for exemption status and conducts itself in full accordance with current guidelines. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and stem cell procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.